Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Burning Rock, Bayer Partner to Develop NGS-based Companion Diagnostic Assays | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Burning Rock, Bayer Partner to Develop NGS-based Companion Diagnostic Assays

Aim to provide diagnostic methods to enable treatment choice for patients with cancer while driving innovation and development in cancer therapy.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Burning Rock Biotech Limited has entered a collaboration with Bayer to develop next-generation sequencing (NGS)-based companion diagnostic assays (CDx), aiming to provide diagnostic methods to enable treatment choice for patients with cancer in China while driving innovation and development in cancer therapy.
 
This collaboration will focus on the development of companion diagnostic products in China, jointly developing NGS-based CDx for Bayer’s growing portfolio of precision cancer therapies.
 
“We are delighted to have established a companion diagnostics collaboration with Bayer, a global leader in the biopharmaceutical industry,” said Mr. Han, Founder and CEO of Burning Rock. “Burning Rock is committed to the comprehensive development of companion diagnostics on a global scale, and we believe that through the integration of our resources and expertise in the field of cancer diagnosis and treatment, this collaboration will set a standard and high-quality model for the joint development of precision diagnostics.
 
Han added, “We aim to make a greater contribution to the advancement of precision oncology, providing more effective treatment options for patients and setting new benchmarks in the medical field.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics